List of insiders holdings for LENZ Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2024-03-28 16:16:06 | 4,250,856 0 | 4,250,856 | Form 13D |
| Alpha Wave Ventures GP Ltd Alpha Wave Global LP Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner | 2024-03-28 16:31:03 | 0 3,612,211 | 3,612,211 | Form 3 |
| Porteus Matthew Director | 2024-02-05 16:31:56 | 3,548,529 0 | 3,548,529 | Form 13G |
| Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC Versant Venture Capital VII L.P. Versant Ventures VII GP L.P. Versant Ventures VII GP-GP LLC 10% Owner | 2024-11-08 17:08:56 | 2,101,199 0 | 2,101,199 | Form 13D |
| EcoR1 Capital LLC 10% Owner | 2024-04-08 14:46:09 | 1,219,774 0 | 1,219,774 | Form 13G |
| Samsara BioCapital L.P. 436 L.P. AKKARAJU SRINIVAS 10% Owner | 2024-03-25 20:42:49 | 1,213,865 0 | 1,213,865 | Form 13G |
| Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 2024-03-25 20:42:49 | 1,213,865 0 | 1,213,865 | Form 13G |
| Stultz Katherine V CHIEF OPERATING OFFICER | 2021-07-01 19:01:02 | 635,316 0 | 635,316 | Form 4 |
| MCCOLLUM JAMES W Director | 2024-05-14 17:29:43 | 95,034 525,565 | 620,599 | Form 4 |
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2023-02-23 17:02:15 | 600,000 0 | 600,000 | Form 4 |
| Schimmelpennink Evert B. President, CEO and Secretary | 2024-07-23 20:16:36 | 387,106 0 | 387,106 | Form 4 |
| Gutry Phil CHIEF BUSINESS OFFICER | 2022-04-13 19:35:46 | 299,941 0 | 299,941 | Form 4 |
| Odrich Marc Chief Medical Officer | 2024-03-25 20:33:36 | 271,071 0 | 271,071 | Form 4 |
| Olsson Shawn Chief Commercial Officer | 2024-03-25 20:34:51 | 254,355 0 | 254,355 | Form 4 |
| Young Alethia Chief Financial Officer | 2023-02-23 17:04:27 | 220,000 0 | 220,000 | Form 4 |
| Guerard Frederic Director | 2024-03-25 20:40:57 | 81,468 0 | 81,468 | Form 4 |
| George Jeffrey P. Director | 2024-03-25 20:38:06 | 27,000 0 | 27,000 | Form 4 |
| Drapkin Kimberlee C Director | 2024-03-25 20:39:32 | 27,000 0 | 27,000 | Form 4 |
| Scheiner Zachary Director | 2024-03-25 20:40:09 | 27,000 0 | 27,000 | Form 4 |
| Thunen Shelley B Director | 2024-03-25 20:44:10 | 27,000 0 | 27,000 | Form 4 |
| Hege Kristen Director | 2023-07-21 17:00:36 | 20,000 0 | 20,000 | Form 4 |
| Viney Joanne L. Director | 2023-07-21 17:13:33 | 20,000 0 | 20,000 | Form 4 |
| KARSEN PERRY A Director | 2023-07-21 17:10:29 | 20,000 0 | 20,000 | Form 4 |
| Shah Smital Director | 2023-07-21 17:01:42 | 20,000 0 | 20,000 | Form 4 |
| JIMENEZ JOSEPH Director | 2023-07-21 17:08:50 | 20,000 0 | 20,000 | Form 4 |
| Jerel Davis Director | 2023-07-21 17:07:08 | 20,000 0 | 20,000 | Form 4 |
| Carlo Rizzuto Director | 2023-07-21 17:05:36 | 20,000 0 | 20,000 | Form 4 |
| Bassan Abraham Director | 2023-07-21 17:02:57 | 20,000 0 | 20,000 | Form 4 |
| Chevallard Daniel R. Chief Financial Officer | 2024-05-15 16:13:06 | 3,188 0 | 3,188 | Form 4 |